Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.
about
Iron therapy in anaemic adults without chronic kidney diseaseSafety of intravenous iron formulations: facts and folkloreEfficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral ironIn vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agentsEfficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice.Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations.Economic evaluation of intravenous iron treatments in the management of anemia patients in GreeceIn vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesIntravenous iron dextran as a component of anemia management in chronic kidney disease: a report of safety and efficacy.Management of Iron Deficiency Anemia.Iron deficiency anemia in patients with inflammatory bowel disease.Perioperative anemia management in colorectal cancer patients: a pragmatic approach.Iron deficiency in the elderly population, revisited in the hepcidin era.Iron deficiency syndromes and iron-restricted erythropoiesis (CME).Ferric carboxymaltose for the treatment of iron-deficiency anemia. [corrected].State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease.How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The use of iron supplementation to reduce ESA dosing in hemodialysis.Hypersensitivity to intravenous iron: classification, terminology, mechanisms and managementHow we diagnose and treat iron deficiency anemia.Bloodless medicine: current strategies and emerging treatment paradigms.Single-dose intravenous iron for iron deficiency: a new paradigm.The available intravenous iron formulations: History, efficacy, and toxicology.Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min.Iron (III) isomaltoside 1000.On the safety of intravenous iron, evidence trumps conjecture.Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy.Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.Treatment of individuals who cannot receive blood products for religious or other reasons.Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK.Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED).Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.Safety and effectiveness of extended versus shortened iron dextran infusion time for the treatment of iron deficiency anemia.Intravenous iron therapy in non-anemic iron-deficient menstruating adolescent females with fatigue.Intravenous Irons: From Basic Science to Clinical Practice
P2860
Q24187098-D8D45ABA-E14F-42B7-B5E5-1649326D967CQ26853397-16B91147-72E3-4227-B3F3-1476A8570F51Q34470847-33529D0C-15A6-4F82-9267-C98CC9D2D8BDQ35232459-C85141DC-EAC3-4A80-82A7-A2297CD813EFQ35864436-9E6666A0-A965-4A27-A4B3-D57F691E4EEEQ35898038-301FB400-E4E6-4DAC-AC81-272CFC463F6FQ35982607-A49F8D3B-979E-4F31-870E-C620961F181AQ36289257-86DEB04B-618C-4BEC-9B4C-53B938EFA3BBQ36734021-54351D01-BD97-4668-9362-D21CEF79B20DQ36812538-59761369-A69F-4C70-90A0-29ABB61F7254Q36918762-3E2EB2B3-14A4-4143-9C6F-F0C1FDB22AE4Q37602724-9630E94D-59D9-4C3F-A44A-DAF521ED03ADQ37734983-EA680013-C48A-4611-B504-DF8F7D79D2D2Q37972641-81387480-E811-4D38-95A1-45E18D792B8BQ37993131-70C23248-C2D5-41FB-8B04-7784761F8988Q38037260-611A7CEF-3293-4F06-8CB5-02D073E678EBQ38114158-B9CACACC-2960-4AC3-AAAC-2CFCB966CACCQ38564991-3DB481E1-EF21-4F20-A5E1-1301ADE62188Q38593099-B4DB26EC-CA3E-44B6-863B-FD33FA5309D9Q38912974-D198455C-3E68-4801-9E53-E6191452A6A1Q39027699-90F215CD-ECB1-436A-8FF9-DC195C735D98Q39216462-24268F97-10B7-4809-A9D6-957BB68339CAQ39390590-A9DA8144-160E-4676-B5A0-D99F114C1118Q39399976-DE306905-AAB4-4F6B-9AF9-D03EF7C71E60Q42573832-3CE9801F-F600-491A-BF82-ADE75C1E41B7Q45029379-4E5AC97E-D6EC-44FC-8566-D3F202C88BA2Q47224814-858BD97A-520F-436A-9E4B-65E20C437650Q47553677-AEEF3685-4BDF-469E-82F4-43C66E6DF183Q47793365-9990BCD6-EBDC-4173-A6A3-4431F5FB11BBQ47887766-B797BA72-3A5B-4258-8942-067F1C226296Q48225857-C4444FC2-C979-4965-8BE8-CA6404118E01Q48279942-36939FA9-925F-4964-BBEE-7CAF7B659F6EQ51676994-BA0B592A-06C6-42E8-901D-E7EC1121A8BEQ57167424-26009CCE-F0C9-4D1B-ACC1-1FFA9C86A41F
P2860
Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Safety and efficacy of rapidly ...... ment of iron deficient anemia.
@en
Safety and efficacy of rapidly administered
@nl
type
label
Safety and efficacy of rapidly ...... ment of iron deficient anemia.
@en
Safety and efficacy of rapidly administered
@nl
prefLabel
Safety and efficacy of rapidly ...... ment of iron deficient anemia.
@en
Safety and efficacy of rapidly administered
@nl
P2093
P356
P1476
Safety and efficacy of rapidly ...... tment of iron deficient anemia
@en
P2093
Harold Ballard
Huzefa Bahrain
Jennifer A Pappadakis
Michael Auerbach
Sarah A Auerbach
P304
P356
10.1002/AJH.22153
P50
P577
2011-08-29T00:00:00Z